RE: CogniCann inhibits the deterioration of Dementia06 Jun 2022 07:55
The Clinical Trial, which commenced in March 2020, initially planned to enrol 50 patients from a number of Aged Care Facilities across Perth, Western Australia, however, as a result of the COVID-19 pandemic, and the resulting restrictions place on accessing Aged Care Facilities by Australian government agencies, the time taken to complete the trial was longer than anticipated, resulting in the number of patients enrolled in the trial being reduced from the initial target of 50 to 22.